InvAscent
InvAscent is a private equity growth capital for pharma, healthcare, animal health, and medtech businesses in India.
Business Model:
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed InvAscent Information
Geographic Data
Address: River Court, St. Denis Street
City: Port Louis
State: port louis
Zip:
Country: MU
Financial Info
Stage:
Raised Last:
$0
Raised Total:$474M
Social
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
InvAscent is the investment advisor to EILSF (Fund I), India Life Sciences Fund II (ILSF-II) and India Life Sciences Fund III (ILSF-III). These funds provide private equity growth capital to companies in the Indian pharmaceutical, healthcare, animal health and medtech industries. Examples of funds usage include capacity expansion, introduction of new products, acquisitions, etc. The typical investment size is in the range of USD 10 - 40 million over the life of the investment for a significant minority stake.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 1/2016 | Sandor | Seed Round | 0 |
| 6/2022 | Accumax | Private Equity Round | 0 |
| 2/2021 | MediBuddy | Series B | 0 |
| 6/2020 | Sharp Sight | Private Equity Round | 9.3M |
| 1/2014 | Oliva Clinic | Series A | 6.7M |
| 12/2016 | Stericon Pharma | Private Equity Round | 7.3M |
| 6/2020 | Murli Krishna Pharma | Private Equity Round | 9.2M |
| 11/2022 | Sunways | Private Equity Round | 14.7M |
| 4/2022 | Malladi Drugs | Private Equity Round | 0 |
| 1/2019 | Intron Life Sciences | Private Equity Round | 10M |
| 10/2018 | Strides Pharma Science | Post-IPO Equity | 0 |
| 3/2017 | Oliva Clinic | Series A | 832k |
| 10/2015 | Synergia Life Sciences | Private Equity Round | 6.1M |
| 6/2022 | Accumax | Private Equity Round | 0 |
| 4/2022 | Malladi Drugs | Private Equity Round | 0 |
| 2/2021 | MediBuddy | Series B | 0 |
| 6/2020 | Murli Krishna Pharma | Private Equity Round | 0 |
| 6/2020 | Sharp Sight | Private Equity Round | 0 |
| 1/2019 | Intron Life Sciences | Private Equity Round | 0 |
| 10/2018 | Strides Pharma Science | Post-IPO Equity | 0 |
| 3/2017 | Oliva Clinic | Series A | 0 |
| 12/2016 | Stericon Pharma | Private Equity Round | 0 |
| 1/2016 | Sandor | Seed Round | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
